| P50 | author | Daniel Sinnett | Q47451414 |
| P2093 | author name string | Z Saikali | |
| | G Boily | |
| P2860 | cites work | Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome | Q24320198 |
| | Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome | Q28139404 |
| | Glypicans in growth control and cancer | Q28185369 |
| | Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene | Q28252018 |
| | Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution | Q28254797 |
| | Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome | Q28291534 |
| | Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization | Q28303036 |
| | DNA methylation: past, present and future directions | Q31530974 |
| | Frequent silencing of the GPC3 gene in ovarian cancer cell lines | Q33852778 |
| | DNA methylation and cancer | Q33875819 |
| | Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma | Q33888628 |
| | DNA methylation in transcriptional repression of two differentially expressed X-linked genes, GPC3 and SYBL1. | Q34828632 |
| | Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders | Q35363234 |
| | Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine | Q36846935 |
| | Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling | Q38359851 |
| | Alterations in DNA methylation: a fundamental aspect of neoplasia | Q41617101 |
| | Glypican-3 expression is silenced in human breast cancer | Q43796931 |
| | Glypican-3 expression in Wilms tumor and hepatoblastoma. | Q52545480 |
| | Allelic losses and DNA methylation at DNA mismatch repair loci in sporadic colorectal cancer. | Q53428133 |
| | Cytosines adjacent to methylated CpG sites can be partially resistant to conversion in genomic bisulfite sequencing leading to methylation artifacts. | Q53960299 |
| | Expression of the novel mitoxantrone resistance associated gene MXR7 in colorectal malignancies. | Q54146523 |
| | Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia | Q56418625 |
| | Glypicans: a growing trend | Q57791371 |
| | Methylation and the X chromosome | Q69684139 |
| | Expression of glypican 3 (GPC3) in embryonal tumors | Q73011824 |
| | Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents | Q73923055 |
| | Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells | Q77639784 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1606-1611 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Methylation analysis of the glypican 3 gene in embryonal tumours | |
| P478 | volume | 90 | |